Security key
15673T100
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)
CUSIP: 15673T100
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 22,151,698
- Total 13F value
- $278,859,136
- Share change
- +1,012,464
- SEC-reported price per share
- $12.59
- Number of holders
- 51
- Value change
- +$11,504,710
- Number of buys
- 28
- Number of sells
- 17
- Shares outstanding
- 180,747,818
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q1 2022
Institutions
51
Top holders
10
IPSC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Century Therapeutics, Inc. SEC filings
Century Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15673T100
Recent filing periods:
Ownership snapshot
Top reported holders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 4.5%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 4.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
FMR LLC
4.5%
Casdin Capital, LLC
1.8%
FEDERATED HERMES, INC.
0.64%
RA CAPITAL MANAGEMENT, L.P.
0.51%
Avidity Partners Management LP
0.47%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
4.5%
|
$129,992,000
8,196,203 shares
|
— | 31 Dec 2021 |
| Casdin Capital, LLC |
13F
Company
|
1.8%
|
$50,853,000
3,206,380 shares
|
— | 31 Dec 2021 |
| FEDERATED HERMES, INC. |
13F
Company
|
0.64%
|
$18,463,000
1,164,094 shares
|
— | 31 Dec 2021 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
0.51%
|
$14,498,000
914,094 shares
|
— | 31 Dec 2021 |
| Avidity Partners Management LP |
13F
Company
|
0.47%
|
$13,505,000
851,522 shares
|
— | 31 Dec 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
0.46%
|
$13,123,000
827,423 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
51
Shares
22,151,698
Rows available
51
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
50
Q1 2022 holders
51
Holder diff
1
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend